Karin Hagerbrand

Title: Innovations by Karin Hagerbrand

Introduction

Karin Hagerbrand is a notable inventor based in Hjarup, Sweden. She has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic polypeptides. With a total of three patents to her name, her work focuses on innovative solutions for cancer treatment.

Latest Patents

Karin's latest patents include groundbreaking inventions related to bispecific polypeptides, such as antibodies, which are designed for the treatment of cancers that express carcinoembryonic antigen (CEA). Additionally, she has developed methods and compositions that provide polypeptides capable of targeting antigens, including neoantigens, to specific immune cells. These polypeptides are primarily antibodies or antibody-based polypeptides, showcasing her commitment to advancing cancer therapies.

Career Highlights

Karin Hagerbrand is currently associated with Alligator Bioscience AB, a company dedicated to developing innovative immunotherapies for cancer treatment. Her work at the company emphasizes her role in pushing the boundaries of current medical science and improving patient outcomes.

Collaborations

Karin collaborates with esteemed colleagues such as Peter Ellmark and Laura Varas, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Karin Hagerbrand's contributions to the field of biotechnology and her innovative patents highlight her as a leading figure in cancer research. Her work continues to pave the way for new therapeutic approaches that could significantly impact patient care.